These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22522615)

  • 1. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
    Sung JY; Park SB; Liu YT; Kwai N; Arnold R; Krishnan AV; Lin CS
    Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    Sung JY; Tani J; Chang TS; Lin CS
    PLoS One; 2017; 12(2):e0171223. PubMed ID: 28182728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory and motor axonal excitability testing in early diabetic neuropathy.
    Kristensen AG; Gylfadottir S; Itani M; Kuwabara S; Krøigård T; Khan KS; Finnerup NB; Andersen H; Jensen TS; Sindrup S; Tankisi H
    Clin Neurophysiol; 2021 Jul; 132(7):1407-1415. PubMed ID: 34030050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal dysfunction prior to neuropathy onset in type 1 diabetes.
    Arnold R; Kwai N; Lin CS; Poynten AM; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2013 Jan; 29(1):53-9. PubMed ID: 23008000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV; Lin CS; Kiernan MC
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between markers of peripheral nerve function and structure in type 1 diabetes.
    Borire AA; Issar T; Kwai NC; Visser LH; Simon NG; Poynten AM; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3028. PubMed ID: 29858541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered nerve excitability properties in established diabetic neuropathy.
    Krishnan AV; Kiernan MC
    Brain; 2005 May; 128(Pt 5):1178-87. PubMed ID: 15758031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy.
    Cappelen-Smith C; Kuwabara S; Lin CS; Burke D
    Muscle Nerve; 2002 Dec; 26(6):769-76. PubMed ID: 12451600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.
    Kwai NC; Nigole W; Poynten AM; Brown C; Krishnan AV
    PLoS One; 2016; 11(4):e0153389. PubMed ID: 27078166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of corneal nerve loss with markers of axonal ion channel dysfunction in type 1 diabetes.
    Tummanapalli SS; Issar T; Kwai N; Poynten A; Krishnan AV; Willcox M; Markoulli M
    Clin Neurophysiol; 2020 Jan; 131(1):145-154. PubMed ID: 31765978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG; Arnold R; Poynten AM; Howells J; Kiernan MC; Lin CS; Krishnan AV
    Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of axonal excitability abnormalities with increasing clinical severity of diabetic peripheral neuropathy.
    Dhanapalaratnam R; Issar T; Poynten AM; Milner KL; Kwai NCG; Krishnan AV
    Clin Neurophysiol; 2024 Apr; 160():12-18. PubMed ID: 38367309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitability of motor and sensory axons in multifocal motor neuropathy.
    Kovalchuk MO; Franssen H; van den Berg LH; van Schelven LJ; Sleutjes BTHM
    Clin Neurophysiol; 2020 Nov; 131(11):2641-2650. PubMed ID: 32947198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral nerve excitability measures at different target levels: the effects of aging and diabetic neuropathy.
    Shibuta Y; Nodera H; Mori A; Okita T; Kaji R
    J Clin Neurophysiol; 2010 Oct; 27(5):350-7. PubMed ID: 20844439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve excitability changes in critical illness polyneuropathy.
    Z'Graggen WJ; Lin CS; Howard RS; Beale RJ; Bostock H
    Brain; 2006 Sep; 129(Pt 9):2461-70. PubMed ID: 16901913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tibial nerve axonal excitability in type 1 diabetes mellitus.
    Gencpinar P; Çelmeli G; Duman Ö; Haspolat Ş; Uysal H
    Muscle Nerve; 2019 Jan; 59(1):76-81. PubMed ID: 30019351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability.
    Farrar MA; Park SB; Lin CS; Kiernan MC
    J Physiol; 2013 Jan; 591(1):273-86. PubMed ID: 23006483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy.
    Farrar MA; Vucic S; Lin CS; Park SB; Johnston HM; du Sart D; Bostock H; Kiernan MC
    Brain; 2011 Nov; 134(Pt 11):3185-97. PubMed ID: 21926101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.